NORD
PINK Nordicus Partners Corp$4.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.00, $0.02 below the day’s high of $4.02
- YTD change
- +63.27%
- vs 20-day SMA
- +7.04%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+1.00 (+33.33%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 2.4% away from all-time highs of $4.10
- NORD is up 63% since the beginning of the year
- NORD is up 63% over the past 12 months
- NORD is up 54% over the past 1 month
- 0% of all NORD investors are betting against NORD
NORD reads n/a: the 12-month move is -16.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +21.21%
- vs 8-day SMA
- +18.30%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.